OWC Pharmaceutical Research Corp. (OWCP)

OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple Myeloma Therapy


OWC Pharmaceutical Research Corp. (OWCP)
A Delaware Corporation since March 6, 2008

2, Ben Gurion Street
5257334 Ramat Gan, Israel

info@owcpharma.com

OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd. ("OWC"), of conducting
medical research and clinical trials, in full compliance with all international regulatory protocols, for the development and improvement of strains of medical cannabis
specifically designed for the treatment of several illnesses/medical conditions including Multiple Myeloma, Psoriasis, Fibromyalgia, Migraine, and PTSD.

 Our business plan includes entering into collaborative ventures with major medical centers and highly regarded researchers in Israel and potentially
other countries with the goal of developing novel therapeutic methods for the treatment of serious medical conditions with cannabis-based therapies and are
conducting pre-clinical investigations and randomized, placebo-controlled trials of cannabis-based compounds and develop unique, condition-specific products.
 

-- February 2018 Investor Presentation --

Download Here

--Intellectual Property--

ALL PUBLISHED PATENT APPLICATIONS NAME ONE WORLD CANNABIS AS THE ASSIGNEE (OWNER)

OWCP's Intellectual Property Portfolio comprises 9 patent families and includes 31 filings in selected domains at various stages from PCT filings, National Phase filings
and Continuations in Part (CIP).  The National Phase is the second of the two main phases of the Patent Cooperation Treaty (PCT) procedure. It follows the international phase and consists
of the processing of the international application before each office of or acting for a contracting state of the PCT that has been designated in the international application.
The table below will be updated when the  unknown patent families and additional patent applications are identified.

Final Action Information from the USPTO

     AUSPAT (Australia) (AU)     Canadian Intellectual Property Office (CA)      European Patent Register (EPR)    Israel Patent Office (IL)     US Patent & Trademark Office (USPTO)       WIPO Patentscope (WIPO)

*The Psoriasis agreement with Sheba Academic Medical Center provides that all intellectual property that is conceived during the course of the research is to be jointly owned by Sheba and One World Cannabis.

-- ACTIVE LITIGATION --

OWC Pharmaceutical Research Corp is the Plaintiff in both cases filed in Supreme Court of New York County.
Link to Filings

DAILY

WEEKLY